What 340B Was Supposed to Do

Congress created the 340B Drug Pricing Program in 1992 with a straightforward goal: require pharmaceutical manufacturers to sell drugs at steep discounts to hospitals serving low-income and uninsured patients.

What It Actually Does

According to Paragon Health Institute President Brian Blase, 340B drug purchases exploded from $5 billion in 2010 to more than $81 billion in 2024. The number of participating hospitals and contract pharmacies has surged alongside those dollars.

The mechanics are straightforward and the incentives are perverse. A hospital buys a drug at the 340B discount, then gets reimbursed by Medicare or insurance at the full market rate. The hospital keeps the spread. No requirement — ZERO — that any of those savings reach the patient.

RealClearHealth reported the result: only $1 is invested in charity care for every $10 in profit collected by profitable 340B hospitals.

The 'Rural' Hospital That Isn't Rural

One of the most glaring examples of the program's drift from its mission involves the Rural Referral Center designation. According to RealClearHealth, 82% of 340B-affiliated Rural Referral Centers are located in urban areas, serving primarily urban patients.

Actual rural communities — the ones with real provider shortages and genuine access problems — see little to no benefit.

Hospitals Using It as a Weapon

Paragon Health Institute's analysis shows the 340B program has become a major driver of hospital consolidation. Because profits scale with drug volume, hospitals are financially incentivized to acquire physician practices, outpatient facilities, and any independent competitor that generates drug referrals.

Hospitals use the revenue not to expand care in underserved neighborhoods, but to push into wealthier, commercially insured markets — where the real money is.

According to Breitbart — in a piece sponsored by Americans for Limited Government — CHRISTUS St. Vincent, a Santa Fe hospital, used its 340B status while simultaneously running an anti-competitive campaign against smaller independent provider Nexus Health.

That same hospital paid $12.24 million in 2017 to settle Medicaid False Claims Act allegations after manipulating county donations to inflate federal matching funds. Then settled a second case for billing services a physician never performed.

The Fraud Layer

A significant number of 340B-registered hospital systems have active Department of Justice fraud settlements on their records.

Breitbart reviewed DOJ settlements and identified a pattern. Across a subset of the worst cases, aggregated settlements collectively exceed half a billion dollars.

The examples include:

• Bon Secours St. Francis Health System paid $36.5 million to resolve kickback allegations tied to physician referral volume. A separate Virginia lawsuit alleged the system credentialed an OB/GYN later convicted of fraud for performing bogus procedures. A 2022 New York Times investigation found the system extracting profit from a low-income Richmond neighborhood while directing resources elsewhere.
• Community Health Network (CHN) in Indianapolis paid $345 million in 2023 — one of the largest False Claims Act settlements in recent memory — to settle allegations it systematically violated the Stark Law. The federal government alleged CHN knowingly overpaid recruited specialists beyond fair market value to capture their downstream Medicare referrals, then paid bonuses directly tied to referral volume.

These aren't billing errors. This is deliberate, systematic fraud.

The Anti-Kickback Infrastructure

The Whistleblower Law Collaborative notes that the biggest False Claims Act recoveries in history have involved pharmaceutical fraud — including off-label drug marketing and illegal kickbacks. The 340B structure creates exactly the kind of financial incentives that historically breed this behavior: high-volume, high-margin drug administration with minimal transparency and weak oversight.

When hospitals profit more by administering more expensive drugs in higher volumes, the financial incentives align with behavior that courts have repeatedly found fraudulent.

What the White House Has — and Hasn't — Done

Vice President J.D. Vance and FTC Chairman Andrew Ferguson launched the White House Fraud Task Force earlier this year. According to Breitbart, the task force has frozen billions in suspect payments and exposed operators billing Medicare for patients who don't exist.

But 340B — sitting at $81 billion and growing — has not been the primary target.

The program is on track to become the largest government drug program in the country, according to Paragon Health Institute. Bigger than Medicaid drug spending. Approaching Medicare Part D territory.

The task force is chasing small fraudsters while a structural, legal fraud machine operates in plain sight.

What Mainstream Media Is Getting Wrong

Most mainstream coverage of 340B frames reform as a fight between Big Pharma (who wants to limit discounts) and hospitals (who want to keep them). That's a false choice designed to protect the status quo.

The real fight is between patients and the hospital systems that are supposed to serve them. Sally Greenberg, writing in RealClearHealth, put it plainly: the program has become a financial bonanza for non-profit hospitals and large chain retail pharmacies, while patients in desperate need don't get the benefits of the discounts.

This is not a left-right issue. Greenberg's piece ran on a centrist health policy outlet. Paragon is center-right. The original criticism came from a 2022 New York Times investigation. The DOJ fraud settlements happened under multiple administrations.

What This Means for You

Higher drug costs. Higher insurance premiums. Independent doctors being bought out or pushed out. Hospital monopolies in your town billing you aggressively for medical debt — while claiming non-profit status and skimming billions in government-mandated drug discounts.

You are paying for this program. The hospitals are keeping the money. The poor aren't seeing the help.

Congress created this mess in 1992 and has had 34 years to fix it. They haven't. Any politician — Republican or Democrat — who defends the 340B status quo is defending fraud, consolidation, and the shafting of low-income patients.